CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 282 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $381,535 | -3.4% | 7,042 | +25.0% | 0.00% | 0.0% |
Q1 2024 | $395,000 | +40.4% | 5,634 | +67.2% | 0.00% | – |
Q4 2023 | $281,278 | -26.4% | 3,369 | -74.0% | 0.00% | -100.0% |
Q3 2023 | $382,097 | -33.2% | 12,970 | -26.0% | 0.00% | 0.0% |
Q2 2023 | $572,090 | -14.6% | 17,538 | -7.9% | 0.00% | 0.0% |
Q1 2023 | $670,017 | -25.6% | 19,040 | -3.1% | 0.00% | -50.0% |
Q4 2022 | $900,271 | -7.9% | 19,648 | -2.6% | 0.00% | 0.0% |
Q3 2022 | $977,000 | -1.7% | 20,171 | -20.2% | 0.00% | 0.0% |
Q2 2022 | $994,000 | +42.0% | 25,291 | +33.0% | 0.00% | +100.0% |
Q1 2022 | $700,000 | -19.9% | 19,017 | -0.9% | 0.00% | 0.0% |
Q4 2021 | $874,000 | +26.3% | 19,182 | -0.9% | 0.00% | 0.0% |
Q3 2021 | $692,000 | +1997.0% | 19,351 | +1047.1% | 0.00% | – |
Q2 2021 | $33,000 | +106.2% | 1,687 | +144.8% | 0.00% | – |
Q1 2021 | $16,000 | +14.3% | 689 | 0.0% | 0.00% | – |
Q4 2020 | $14,000 | +40.0% | 689 | +53.8% | 0.00% | – |
Q3 2020 | $10,000 | +150.0% | 448 | +135.8% | 0.00% | – |
Q2 2020 | $4,000 | +100.0% | 190 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 190 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 190 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 190 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 190 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 190 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 190 | +31.9% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 144 | +94.6% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 74 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 74 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | -95.8% | 74 | -96.8% | 0.00% | – |
Q4 2015 | $24,000 | +33.3% | 2,284 | -12.9% | 0.00% | – |
Q3 2015 | $18,000 | -25.0% | 2,621 | -26.2% | 0.00% | – |
Q2 2015 | $24,000 | -4.0% | 3,550 | -2.2% | 0.00% | – |
Q1 2015 | $25,000 | -16.7% | 3,629 | -1.7% | 0.00% | – |
Q4 2014 | $30,000 | +114.3% | 3,693 | -7.5% | 0.00% | – |
Q3 2014 | $14,000 | -26.3% | 3,993 | +0.5% | 0.00% | – |
Q2 2014 | $19,000 | -50.0% | 3,975 | 0.0% | 0.00% | – |
Q1 2014 | $38,000 | +58.3% | 3,975 | +7.8% | 0.00% | – |
Q4 2013 | $24,000 | -14.3% | 3,686 | 0.0% | 0.00% | – |
Q3 2013 | $28,000 | – | 3,686 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |